Lectin compositions and methods for modulating an immune response to an antigen
Abstract
The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
Claims
exact text as granted — not AI-modified1 . A nucleic acid molecule encoding a fusion polypeptide comprising:
a first amino acid sequence which can bind to a carbohydrate and is HA; and a second amino acid sequence comprising amino acids of GM-CSF.
2 . The nucleic acid molecule of claim 1 , wherein said first amino acid sequence is N-terminal to said second amino acid sequence; or wherein said first amino acid sequence is C-terminal to said second amino acid sequence.
3 . The nucleic acid molecule of claim 1 , wherein said GM-CSF binds to a human GM-CSF receptor.
4 . The nucleic acid molecule of claim 1 , wherein said GM-CSF binds to a GM-CSF receptor of a cell selected from the group consisting of a leukocyte, an antigen presenting cell, a professional antigen presenting cell, and a dendritic cell.
5 . The nucleic acid molecule of claim 1 , wherein said encoded fusion polypeptide further comprises a linker interposed between said first and second amino acid sequences.
6 . The nucleic acid molecule of claim 5 , wherein the linker has the formula (Gly x Ser) n , wherein n is an integer between 1 and 15, and x is an integer between 1 and 10.
7 . The nucleic acid molecule of claim 1 , wherein the encoded fusion polypeptide further comprises a secretory signal sequence.
8 . An expression vector containing the nucleic acid molecule of claim 1 .
9 . The expression vector of claim 8 , which is a mammalian expression vector.
10 . A host cell comprising the nucleic acid molecule of claim 1 .
11 . The nucleic acid molecule of claim 1 , wherein said second amino acid sequence comprises at least five contiguous amino acids of GM-CSF.
12 . A method of stimulating an immune response to an antigen in a subject comprising:
administering to the subject a nucleic acid molecule encoding a fusion polypeptide comprising:
a first amino acid sequence which can bind to a carbohydrate and is HA; and
a second amino acid sequence comprising amino acids of GM-CSF,
wherein an immune response to the antigen is stimulated in the subject following administration of the nucleic acid molecule.Join the waitlist — get patent alerts
Track US2018237487A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.